The first full week of November delivers a broad and high-impact earnings lineup across semiconductors, cloud software, AI, consumer retail, healthcare, cannabis, energy, media, and crypto-linked names, offering one of the most diversified snapshots of corporate sentiment this quarter.
Semiconductors & AI Infrastructure lead the spotlight, with Advanced Micro Devices (AMD), QUALCOMM (QCOM), Super Micro Computer (SMCI), ON Semiconductor (ON), Arista Networks (ANET), and Skyworks Solutions (SWKS) reporting. These results will help shape expectations around AI server demand, edge compute, and smartphone recovery cycles.
Cloud, Software, and AI Platforms including Palantir (PLTR), The Trade Desk (TTD), Unity Software (U), Datadog (DDOG), AppLovin (APP), Upstart (UPST), Fastly (FSLY), IonQ (IONQ), and Lemonade (LMND) will offer signals on AI adoption momentum, enterprise budgets, and application layer monetization.
In the consumer and services space, we’ll hear from McDonald’s (MCD), Airbnb (ABNB), Uber (UBER), Shopify (SHOP), DraftKings (DKNG), Peloton (PTON), Pinterest (PINS), Snap (SNAP), Rivian (RIVN) and Beyond Meat (BYND) as markets assess consumer resilience, discretionary spend, traffic volumes, and unit economics.
Healthcare & Biotech remains in focus with earnings from Pfizer (PFE), Moderna (MRNA), Amgen (AMGN), Vertex Pharma (VRTX), AstraZeneca (AZN), Novo Nordisk (NVO), Teva Pharma (TEVA), and Viatris (VTRS) amid ongoing discussions around drug pricing, GLP-1 demand, and innovation pipelines.
Energy, Refining & Commodities updates arrive from ConocoPhillips (COP), Marathon Petroleum (MPC), EOG Resources (EOG), Suncor (SU), BP (BP), Energy Transfer (ET), MPLX (MPLX), Petrobras (PBR) and Wheaton Precious Metals (WPM), providing a read on global supply, commodity pricing, and refining margins.
Financials, Real Estate & Asset Managers including Realty Income (O), Simon Property Group (SPG), Main Street Capital (MAIN), Blue Owl Capital (OBDC), Innovative Industrial Properties (IIPR), Brookfield Asset Management (BAM), and NNN REIT (NNN) will shed light on credit demand, commercial real estate exposure, and distribution stability.
Media, gaming, and streaming highlights include Warner Bros. Discovery (WBD), Take-Two Interactive (TTWO), Spotify (SPOT), and AMC Entertainment (AMC), alongside MARA (MARA) and Robinhood (HOOD) on the crypto-adjacent side.
The week concludes with industrial and materials names: DuPont (DD), Archer-Daniels-Midland (ADM), Emerson Electric (EMR), Nutrien (NTR), MP Materials (MP), and Cameco (CCJ), key for signals on manufacturing health, agricultural demand, and the rare-earths & uranium supply chain.
With so many cross-sector bellwethers on the calendar, this week is poised to provide a critical read on Q4 macro momentum, capital spending discipline, and investor positioning into year-end.
Below is a rundown of major earnings reports due in the week of November 3 to November 7:
Monday, November 3
Palantir Technologies (PLTR)
Palantir Technologies (PLTR) is set to release its Q3 earnings after the close, consensus calling for about a 67% rise in EPS and over 50% Y/Y revenue growth.
The stock has surged roughly 157% YTD, yet both Wall Street and Seeking Alpha’s Quant Rating keep a Hold due to valuation concerns.
Piper Sandler lifted its price target to $210 from $182 while keeping an Overweight stance. Analyst Clarke Jeffries notes Palantir’s valuation leaves little room for error if growth slows but cites strong visibility into future revenue (defined contract value >$7B plus IDIQ ~${4}B), rapid Commercial bookings growth, and a large addressable opportunity in U.S. Defense spending. The defense shift toward software and unmanned systems suggests upside, with Jeffries noting that even a 0.5% shift of defense spending to Palantir could quintuple government revenue, though it would still be small next to Lockheed Martin.
Bearish views from Seeking Alpha’s Investing Group Leader Beth Kindig highlight 93% Y/Y and 20% sequential growth in US commercial revenue but emphasize that government revenue remains Palantir’s core. Government revenue accounted for about 55% of the total. At roughly 105x forward P/S, Palantir trades at a premium vs. peers like Cloudflare (~35.5x) and CrowdStrike (~25.2x), raising questions about how much future upside is already reflected in the share price.
- Consensus EPS Estimates: $0.17
- Consensus Revenue Estimates: $1.09B
- Earnings Insight: The stock has beaten revenue and EPS expectations in 8 consecutive quarters.
Also reporting: Realty Income (O), Simon Property Group (SPG), Vertex Pharmaceuticals (VRTX), fuboTV (FUBO), Innovative Industrial Properties (IIPR), Qorvo (QRVO), BioNTech SE (BNTX), Williams Companies (WMB), Clorox (CLX), ON Semiconductor (ON), Diamondback Energy (FANG), Oxford Lane Capital (OXLC), Exact Sciences (EXAS), BioCryst Pharmaceuticals (BCRX), Upwork (UPWK), IDEXX Laboratories (IDXX), Goodyear Tire & Rubber Company (GT), and more.
Tuesday, November 4
Advanced Micro Devices (AMD)
Advanced Micro Devices (AMD) is set to report its Q3 earnings after the market closes on Tuesday, analysts expecting a robust over 27% Y/Y revenue and profit gain.
The stock has more than doubled in 2025, yet sentiment remains divided. Wall Street analysts maintain a Buy rating, while Seeking Alpha’s Quant Rating system shifted to a more cautious Hold from Strong Buy ahead of earnings.
Mizuho recently raised its price target on AMD to $275 from $205, reiterating an Outperform view. The firm highlighted AMD’s high-profile AI partnership with OpenAI to deliver large-scale infrastructure, a deal expected to contribute tens of billions of dollars to AMD’s revenue pipeline over the coming years. Mizuho now projects roughly $14B in incremental revenue in fiscal 2027 and as much as $22B annually by 2030, with EPS potentially doubling by 2027–2028. However, the firm also noted that these projections depend heavily on continued funding stability from OpenAI and its backers, introducing an element of execution risk.
Seeking Alpha contributor Star Investments also maintains a Buy outlook, arguing that AMD’s OpenAI partnership represents a turning point in its positioning within the AI chip race. The deal, along with rising data center momentum, has led analysts to sharply raise estimates for 2026 and 2027 revenue and earnings. From this perspective, AMD is emerging as the strongest alternative to NVIDIA in the AI compute market, with accelerating growth making the stock attractive for long-term investors despite near-term volatility.
However, bearish views counter that the market may be pricing in too much too soon. Bears of Wall Street argues that AMD’s valuation has become stretched, noting that the OpenAI partnership is non-exclusive and that meaningful financial benefits may not appear until late 2026 or beyond. With AMD trading around 60x forward earnings, above NVIDIA despite weaker margins and cash flow, the contributor estimates intrinsic value closer to ~$62 per share, significantly below current levels.
Similarly, Seeking Alpha Investing Group Leader Danil Sereda recently downgraded AMD to Hold ahead of earnings due to overvaluation and limited near-term upside, arguing sentiment has become overly optimistic and could lead to a post-earnings pullback despite long-term AI and data-center momentum.
- Consensus EPS Estimates: $1.17
- Consensus Revenue Estimates: $8.75B
- Earnings Insight: AMD has surpassed EPS expectations in 6 of the past 8 quarters, and revenue in 100% of those reports.
Pfizer (PFE)
Pfizer (PFE) is slated to report its Q3 earnings before the market opens on Tuesday, with Wall Street expecting earnings per share to decline about 40% Y/Y as the company continues to adjust from peak COVID-era revenue levels. The stock remains under pressure, but recent clinical progress has added a constructive note to the outlook.
The company recently announced positive Phase 3 topline results for Tukysa as a first-line maintenance therapy in HER2-positive breast cancer, showing a favorable safety profile and improved progression-free survival. Tukysa is currently indicated in the U.S. as a late-line therapy for HER2-positive advanced disease. HER2CLIMB-05 tested Tukysa with first-line standard-of-care maintenance therapy (trastuzumab and pertuzumab) and met its primary endpoint.
Analysts remain divided. Sell-side peers largely maintain a Buy rating, while Seeking Alpha’s Quant Rating is cautious, signaling a Hold due to growth concerns.
Takeaways from sentiment on SA:
Seeking Alpha Investing Group contributor The Alpha Analysts argues that many of these pressures are already priced in. With Pfizer trading near ~8x earnings—well below historical averages—the potential approval and uptake of pipeline assets, including in obesity and metabolic disease, could support a re-rating and capital appreciation over time. They maintain a cautious Buy, citing dividend support and the possibility of 20%–30% upside if revenue stabilizes.
By contrast, contributor Hunting Alpha recommends a Hold, noting that Pfizer’s path into the obesity drug market is coming primarily through acquisition rather than internal development. While the valuation paid was reasonable, the strategy adds execution and integration risks. The contributor highlights that Pfizer remains undervalued relative to peers, yet earnings growth remains weak, and technical indicators suggest the stock has not yet convincingly reversed its downtrend.
- Consensus EPS Estimates: $0.64
- Consensus Revenue Estimates: $16.52B
- Earnings Insight: Pfizer has beaten EPS estimates in 8 straight quarters, exceeding revenue estimates in 5 of those reports.
Also reporting: Shopify (SHOP), BP (BP), Amgen (AMGN), Uber Technologies (UBER), Pinterest (PINS), 3D Systems (DDD), Skyworks Solutions (SWKS), Beyond Meat (BYND), Upstart Holdings (UPST), Corteva (CTVA), Suncor Energy (SU), Sundial Growers (SNDL), Spotify Technology S.A. (SPOT), Marathon Digital Holdings (MARA), Digital Turbine (APPS), Archer-Daniels-Midland (ADM), Norwegian Cruise Line Holdings (NCLH), Rivian Automotive (RIVN), American International Group (AIG), MPLX LP (MPLX), Tanger Factory Outlet Centers (SKT), Marathon Petroleum (MPC), Arista Networks (ANET), Clean Energy Fuels (CLNE), AFLAC (AFL), Mosaic (MOS), NNN REIT (NNN), Marriott International (MAR), Macerich Company (MAC), Kinross Gold (KGC), Uniti Group (UNIT), and more.
Wednesday, November 5
McDonald’s (MCD)
McDonald’s (MCD), the world’s second-largest restaurant chain, is set to unveil its Q3 earnings on Wednesday, with analysts expecting revenue and profit to rise a little over 3% Y/Y.
The company recently raised its quarterly dividend by 5% to $1.86/share, reflecting continued confidence in its cash generation.
Wall Street and Seeking Alpha’s Quant model both maintain a Buy rating on the stock.
However, opinion among SA analysts remains split:
Daniel Javier maintains a Hold rating, noting McDonald’s remains a global leader with strong brand equity and a durable franchise model. But he flags inflation pressures, competitive intensity, customer experience concerns, and potential overexpansion as risks to margins and long-term growth. Javier believes the stock looks overvalued, with limited near-term upside, suggesting investors hold or trim rather than exit.
Florian Muller moves to a cautious Buy, calling McDonald’s a defensive anchor amid market volatility. He highlights high-margin franchising, strengthening loyalty programs, and resilient global demand, especially among younger consumers. While valuation is stretched, he argues the stock’s low beta, premium brand positioning, and anticipated earnings growth help justify it. He sees value meals as strategic loss leaders aimed at long-term customer retention. Risks include shifting consumer habits and the rising popularity of weight-loss drugs, but Muller believes the company is well-positioned for uncertain macro conditions.
- Consensus EPS Estimates: $3.33
- Consensus Revenue Estimates: $7.09B
- Earnings Insight: McDonald’s has missed EPS estimates only once in the past 8 quarters, while missing revenue estimates twice in that span.
Also reporting: QUALCOMM (QCOM), Energy Transfer LP (ET), Lucid Group (LCID), Iron Mountain (IRM), AMC Entertainment Holdings (AMC), Snap (SNAP), Unity (U), Teva Pharmaceutical Industries (TEVA), Fastly (FSLY), Nutrien (NTR), Lemonade (LMND), Devon Energy (DVN), Albemarle (ALB), Fiverr International (FVRR), Emerson Electric (EMR), Fortinet (FTNT), SolarEdge Technologies (SEDG), Apache (APA), Brookfield Renewable Partners (BEP), Cameco (CCJ), Novo Nordisk A/S (NVO), MannKind Corp (MNKD), Metlife (MET), PPL Corporation (PPL), Ocugen (OCGN), Lyft (LYFT), and more.
Thursday, November 6
Airbnb (ABNB)
Airbnb (ABNB) is set to release its Q3 earnings on Thursday after the market close. Analysts expect revenue and profit to climb roughly 9% Y/Y.
Both Wall Street and Seeking Alpha’s Quant system currently rate the stock a Hold, citing slowing growth and valuation concerns.
But SA analysts’ sentiment remains divided:
Dilantha De Silva maintains a hold, noting Airbnb’s strong profitability trajectory since 2021, but moderating revenue growth has limited stock performance. He will be watching management’s commentary on expansion markets (short term), hotel partnerships (medium term), and broader strategic growth pathways to assess earnings sustainability going forward.
Andres Veurink reiterates a Buy, calling Airbnb a long-term compounder with asset-light operations, expanding market share, and improving margins. He highlights aggressive share buybacks and a debt-free balance sheet, projecting a 2029 price target of $245–$265 (~107–124% upside), and sees near-term strength into Q3 peak travel demand. Regulatory headwinds persist, but he maintains high conviction in ABNB’s outlook.
YR Research contrasts with a Sell rating, arguing Airbnb is losing share to Booking Holdings (BKNG), even in its core alternative accommodation category. The firm criticizes Airbnb’s emphasis on Experiences rather than a deeper hotel push, suggesting margin pressure and strategic drift. While growth remains solid, EPS expansion is projected to lag peers, yet the stock continues to trade at a premium valuation, prompting a Sell call.
- Consensus EPS Estimates: $2.32
- Consensus Revenue Estimates: $4.08B
- Earnings Insight: Airbnb has surpassed revenue expectations for 8 consecutive quarters and beaten EPS estimates in 5 of those reports.
Also reporting: Viatris (VTRS), Moderna (MRNA), ConocoPhillips (COP), Trade Desk (TTD), DraftKings (DKNG), Main Street Capital Holdings (MAIN), Novavax (NVAX), DuPont (DD), AstraZeneca (AZN), Cronos Group (CRON), Wheaton Precious Metals (WPM), Peloton Interactive (PTON), Datadog (DDOG), Under Armour (UAA), Blink Charging (BLNK), Cummins (CMI), Wynn Resorts (WYNN), Warner Bros. Discovery (WBD), Dropbox (DBX), PENN Entertainment (PENN), Consolidated Edison (ED), Opendoor Technologies (OPEN), Affirm Holdings (AFRM), Under Armour (UA), GoPro (GPRO), Chimera Investment (CIM), Take-Two Interactive Software (TTWO), and more.
Friday, November 7
Enbridge (ENB)
Enbridge (ENB) is set to report its Q3 results during the premarket hours on Friday. Analysts expect profits to decline ~7% Y/Y and revenue to fall more than 20%.
Meanwhile, the U.S. Army Corps of Engineers recently approved Enbridge’s $450M plan to reroute a 41-mile segment of its Line 5 pipeline around the Bad River Band of Lake Superior Chippewa reservation in Wisconsin. The company has until June 2026 to remove 12 miles of pipeline from tribal land under a court order. Environmental groups criticized the approval as premature, citing ongoing state-level litigation. The Line 5 reroute is separate from Enbridge’s proposed underground tunnel project beneath the Straits of Mackinac, which is also tied up in legal disputes.
Ahead of earnings, Seeking Alpha’s Quant Rating system upgraded ENB to Strong Buy from a Hold, aligning with Wall Street’s Buy stance.
According to bullish Seeking Alpha Investing Group Leader Danil Sereda, Enbridge remains well-positioned for steady cash flow growth due to its regulated and contract-backed asset base, which shields the business from commodity price swings. Sereda also highlights the company’s increasing involvement in supplying energy infrastructure for data centers and AI-related power demand. With a ~5.7% dividend yield and what he views as a discounted valuation, he sees potential for roughly 35% upside over time.
- Consensus EPS Estimates: $0.37
- Consensus Revenue Estimates: $8.44B
- Earnings Insight: Shopify has beaten EPS and revenue estimates in 5 of the past 8 quarters.
Also reporting: Canopy Growth (CGC), Enbridge (ENB), Duke Energy (DUK), EOG Resources (EOG), Brookfield Asset Management (BAM), Brookfield Infrastructure Partners L.P. (BIP), KKR & Co. L.P. (KKR), Fulgent Genetics (FLGT), Franklin Resources (BEN), Algonquin Power & Utilities (AQN), Global Partners LP (GLP), Wendy’s International (WEN), Fluor (FLR), and more.